NCT03124498View on ClinicalTrials.gov

A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL

CIK Cell

Autologous cytokine-induced killer (CIK) cell

Sponsors
All Listed Sponsors
lead

Chuan An Biotechnology Co., Ltd.

INDUSTRY

NCT03124498 - A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA | Biotech Hunter | Biotech Hunter